Unveiling 14 Analyst Insights On 3M
Portfolio Pulse from Benzinga Insights
14 analysts have recently reviewed 3M (NYSE:MMM), showing a mix of opinions with a shift towards a more cautious outlook over the last quarter. The average 12-month price target for 3M has been adjusted to $100.29, down from $105.87, indicating a 5.27% decrease. Analyst actions include various adjustments to ratings and price targets, reflecting changing market dynamics and company performance. 3M's financial health indicators such as market capitalization, revenue growth, net margin, ROE, and ROA suggest a strong financial performance despite a slight revenue decline.
April 17, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
3M has seen a diverse range of analyst opinions, with a recent shift towards a more cautious outlook. The average 12-month price target has decreased by 5.27% to $100.29. Despite this, 3M's strong financial health indicators such as market capitalization, net margin, ROE, and ROA suggest resilience.
The mixed analyst ratings and the decrease in the average price target suggest a cautious but not overtly negative outlook for 3M in the short term. The strong financial health indicators, including market capitalization, net margin, ROE, and ROA, provide a counterbalance to the slight revenue decline and the cautious sentiment from analysts, suggesting a neutral impact on the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100